Trading Ideas Genmab A/S

Equities

GMAB

DK0010272202

Real-time Estimate Cboe Europe Other stock markets 09:28:05 2024-06-10 am EDT			5-day change	1st Jan Change
1,927 ^DKK	-0.14%		-1.38%	-10.60%

Jun. 04	Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating	MT
Jun. 03	Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study	MT

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GENMAB A/S :The comeback of an upward trend can be anticipated	Mar. 11
GENMAB A/S :Expectation of a turn-around	Jan. 25
GENMAB A/S :Expectation of a turn-around	Jan. 04
GENMAB A/S :The comeback of an upward trend can be anticipated	Dec. 08
GENMAB A/S :Technically solid	22-11-16
GENMAB A/S :Buyers are coming back	22-08-12
GENMAB A/S :Comeback of a rising trend?	22-03-31
GENMAB A/S :The underlying trend is to the upside	20-06-15
GENMAB A/S :The underlying trend is to the upside	20-01-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab: A good start to 2024; guidance unchanged

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 01:08 pm EDT

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer